Celularity (CELU) EPS (Basic) Growth (3y) (2022 - 2025)
Powered by 
Analysis
Celularity (CELU) EPS (Basic) Growth (3y) (2022 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.20 Bn | 9.35 Bn | 112.79 Mn | 51.67% |
| 2 | CRISPR Therapeutics AG | 5.03 Bn | 5.03 Bn | - | - |
| 3 | Iovance Biotherapeutics | 3.64 Bn | 3.35 Bn | 55.72 Mn | 39.50% |
| 4 | Legend Biotech | 3.54 Bn | 2.58 Bn | 251.50 Mn | 32.71% |
| 5 | uniQure | 2.98 Bn | 2.98 Bn | 5.49 Mn | - |
| 6 | Beam Therapeutics | 2.54 Bn | 2.54 Bn | - | - |
| 7 | Precigen | 2.38 Bn | 2.38 Bn | 52.17 Mn | - |
| 8 | Sarepta Therapeutics | 2.16 Bn | 1.37 Bn | 251.87 Mn | 44.39% |
| 9 | Vericel | 1.93 Bn | 1.77 Bn | 56.40 Mn | 34.14% |
| 10 | Celularity | 36.65 Mn | 30.48 Mn | -3.27 Mn | -36.54% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -36.54% |
| Sep 30, 2025 | -66.35% |
| Jun 30, 2025 | -31.99% |
| Mar 31, 2025 | 44.10% |
| Dec 31, 2024 | -0.26% |
| Sep 30, 2024 | -29.19% |
| Jun 30, 2024 | 74.69% |
| Mar 31, 2024 | 70.39% |
| Dec 31, 2023 | -36.80% |
| Sep 30, 2023 | 54.65% |
| Jun 30, 2023 | 42.01% |
| Mar 31, 2023 | -36.80% |
| Dec 31, 2022 | 22.73% |
| Sep 30, 2022 | -36.24% |
| Jun 30, 2022 | 98.37% |
| Mar 31, 2022 | -3,003.19% |